Akoya Biosciences Inc.

1.34
-0.01 (-0.74%)
At close: Apr 02, 2025, 3:59 PM
1.35
0.44%
After-hours: Apr 02, 2025, 07:56 PM EDT

Akoya Biosciences Statistics

Share Statistics

Akoya Biosciences has 49.82M shares outstanding. The number of shares has increased by 0.87% in one year.

Shares Outstanding 49.82M
Shares Change (YoY) 0.87%
Shares Change (QoQ) 0.51%
Owned by Institutions (%) 24.51%
Shares Floating 20.76M
Failed to Deliver (FTD) Shares 11.15K
FTD / Avg. Volume 1.64%

Short Selling Information

The latest short interest is 1.6M, so 3.23% of the outstanding shares have been sold short.

Short Interest 1.6M
Short % of Shares Out 3.23%
Short % of Float 3.23%
Short Ratio (days to cover) 13.43

Valuation Ratios

The PE ratio is -2.04 and the forward PE ratio is -4.74. Akoya Biosciences's PEG ratio is 0.09.

PE Ratio -2.04
Forward PE -4.74
PS Ratio 1.39
Forward PS 0.5
PB Ratio 14.9
P/FCF Ratio -2.43
PEG Ratio 0.09
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Akoya Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 1.05.

Current Ratio 2.61
Quick Ratio 1.78
Debt / Equity 1.05
Debt / EBITDA -0.21
Debt / FCF -0.17
Interest Coverage -4.48

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $398.4K
Profits Per Employee $-270.07K
Employee Count 205
Asset Turnover 0.65
Inventory Turnover 1.39

Taxes

Income Tax 146K
Effective Tax Rate -0.26%

Stock Price Statistics

The stock price has increased by -69.05% in the last 52 weeks. The beta is 1.32, so Akoya Biosciences's price volatility has been higher than the market average.

Beta 1.32
52-Week Price Change -69.05%
50-Day Moving Average 2.03
200-Day Moving Average 2.42
Relative Strength Index (RSI) 30.38
Average Volume (20 Days) 679.6K

Income Statement

In the last 12 months, Akoya Biosciences had revenue of 81.67M and earned -55.37M in profits. Earnings per share was -1.12.

Revenue 81.67M
Gross Profit 47.88M
Operating Income -46.73M
Net Income -55.37M
EBITDA -37.14M
EBIT -44.79M
Earnings Per Share (EPS) -1.12
Full Income Statement

Balance Sheet

The company has 11.78M in cash and 7.96M in debt, giving a net cash position of 3.81M.

Cash & Cash Equivalents 11.78M
Total Debt 7.96M
Net Cash 3.81M
Retained Earnings -285.44M
Total Assets 125M
Working Capital 47.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -44.1M and capital expenditures -2.46M, giving a free cash flow of -46.56M.

Operating Cash Flow -44.1M
Capital Expenditures -2.46M
Free Cash Flow -46.56M
FCF Per Share -0.94
Full Cash Flow Statement

Margins

Gross margin is 58.62%, with operating and profit margins of -57.22% and -67.79%.

Gross Margin 58.62%
Operating Margin -57.22%
Pretax Margin -67.61%
Profit Margin -67.79%
EBITDA Margin -45.47%
EBIT Margin -57.22%
FCF Margin -57.01%

Dividends & Yields

AKYA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for AKYA is $3, which is 123.9% higher than the current price. The consensus rating is "Hold".

Price Target $3
Price Target Difference 123.9%
Analyst Consensus Hold
Analyst Count 7
Stock Forecasts

Scores

Altman Z-Score 0.27
Piotroski F-Score 4